Antiproliferative effect of deferiprone on the Hep G2 cell line (Q41004730)

25 September 2017

title

Antiproliferative effect of deferiprone on the Hep G2 cell line (English)

1 reference

25 September 2017

N Chenoufi

1

1 reference

25 September 2017

B Drénou

2

1 reference

25 September 2017

O Loréal

3

1 reference

25 September 2017

C Pigeon

4

1 reference

25 September 2017

P Brissot

5

1 reference

25 September 2017

G Lescoat

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

25 September 2017

published in

Biochemical Pharmacology

1 reference

25 September 2017

volume

56

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

431-437

1 reference

Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

The uptake of iron and transferrin by the human malignant melanoma cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Evaluation of new iron chelators for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Iron-chelation therapy with oral deferiprone in patients with thalassemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Ribonucleotide Reductase—a Radical Enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900071-9

10.1016/S0006-2952(98)00071-9

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference